Orthopediatrics (KIDS) Net Income towards Common Stockholders (2016 - 2026)

Orthopediatrics (KIDS) has reported Net Income towards Common Stockholders for 11 consecutive years, with -$7.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 0.7% year-over-year to -$7.2 million in Q2 2026; TTM through Jun 2026 was -$39.7 million, a 4.87% increase from a year earlier, with the FY2025 full-year figure at -$39.6 million, down 4.83% from the prior year.
• Net Income towards Common Stockholders was -$7.2 million for Q2 2026 at Orthopediatrics, up from -$10.7 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $18.5 million in Q3 2022 and troughed at -$16.1 million in Q4 2024.
• A 5-year average of -$6.4 million and a median of -$7.5 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The widest YoY moves for Net Income towards Common Stockholders: up 943.83% in 2022, down 11000.0% in 2022.
• Over 5 years, Net Income towards Common Stockholders stood at -$7.8 million in 2022, then grew by 14.74% to -$6.7 million in 2023, then slumped by 140.16% to -$16.1 million in 2024, then jumped by 37.13% to -$10.1 million in 2025, then climbed by 29.1% to -$7.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$7.2 million (Q2 2026), -$10.7 million (Q1 2026), and -$10.1 million (Q4 2025), per Business Quant data.